SAN DIEGO, Calif., Sept. 29, 2014 /PRNewswire/ -- Molecular Response (MRL), a privately held molecular diagnostic laboratory and a leader in the identification of target populations for high value therapeutics, has opened a new, purpose-built facility in the Torrey Pines biotech campus on 11011 Torreyana Road in San Diego. The new facility, equipped with its exclusive vivarium, is CLIA-certified, and accredited by the College of American Pathologists (CAP).
The CAP Laboratory Accreditation Program is an internationally recognized program that utilizes teams of practicing laboratory professionals as inspectors. Designed to go well beyond regulatory compliance, the CAP program helps laboratories achieve the highest standards of excellence to ensure optimal patient care. Upon successful completion of the inspection process, the laboratory is awarded CAP accreditation and becomes part of an exclusive group of more than 7,000 laboratories worldwide that have met the highest standards of excellence.
MRL's Medical Director, Howard Robin, M.D., was congratulated by the College of American Pathologists for the accreditation and the excellent services being provided by MRL.
"This national recognition underlines Molecular Response's commitment to quality and excellence in patient care," said Cyrus K. Mirsaidi, CEO of Molecular Response. "We have demonstrated our commitment to cancer diagnosis and treatment based on targeted therapeutics with launch of our predictive assay for melanoma patients with advanced disease. We will continue to expand our laboratory menu with new functional assays for common and difficult to treat oncologic diseases."
About Molecular Response
Molecular Response is a leader in advancing targeted therapeutics through intelligently designed, clinically validated diagnostic tests. Our goal is to reduce risk and cost of therapeutic drug development for our partners by translating clinically relevant molecular response marker data into high-value knowledge while fully integrated into existing pharmaceutical development processes and programs. Our results reduce risk and cost of drug development and allow for the most informed decisions with best chance of success to advance therapeutic programs.
For additional information please visit www.molecularresponse.com.
About the College of American Pathologists
The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society serving more than 18,000 physician members and the global laboratory community. It is the world's largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care.
More information at www.cap.org
SOURCE Molecular Response